Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11649999 | 0.77 | PKM (0.35) | PKMSMN1; SMN2 | |
| SCHEMBL9307830 | 0.76 | PKM (0.33) | PKMSMN1; SMN2 | |
| SCHEMBL2987279 | 0.72 | TSHR (0.35) | PKMSMN1; SMN2 | |
| SCHEMBL16987216 | 0.71 | TSHR (0.33) | PKMSMN1; SMN2 | |
| SCHEMBL11681266 | 0.71 | MAPT (0.37) | PKMSMN1; SMN2 | |
| SCHEMBL28766345 | 0.70 | LPAR2 (0.33) | — | |
| SCHEMBL18177935 | 0.69 | CYP3A4 (0.38) | PKMSMN1; SMN2 | |
| SCHEMBL11682393 | 0.68 | ALDH1A1 (0.33) | PKMSMN1; SMN2 | |
| SCHEMBL11308533 | 0.67 | BTN3A1 (0.31) | — | |
| SCHEMBL3268744 | 0.67 | LPAR2 (0.35) | PKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020107401-A1 | Production of phosphonopyrazoles | MONSNTO TECHNOLOGY LLC. | 2002-08-08 | — | — | US | claimed |
| EP-1149108-A1 | PRODUCTION OF PHOSPHONOPYRAZOLES | Monsanto Co. (US) | 2001-10-31 | — | — | EP | claimed |
| WO-2000046229-A1 | PRODUCTION OF PHOSPHONOPYRAZOLES | MONSANTO TECHNOLOGY LLC (US) | 2000-08-10 | — | — | WO | claimed |
| US-20020107401-A1 | Production of phosphonopyrazoles | MONSNTO TECHNOLOGY LLC. | 2002-08-08 | — | — | US | disclosed |
| EP-1149108-A1 | PRODUCTION OF PHOSPHONOPYRAZOLES | Monsanto Co. (US) | 2001-10-31 | — | — | EP | disclosed |
| US-6297194-B1 | INDUCING MALE STERILITY IN PLANTS BY TREATING PLANTS OR SEEDS WITH GAMETOCIDES | MONSANTO TECHNOLOGY, LLC | 2001-10-02 | — | — | US | disclosed |
| WO-2000046229-A1 | PRODUCTION OF PHOSPHONOPYRAZOLES | MONSANTO TECHNOLOGY LLC (US) | 2000-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107401-A1 | Production of phosphonopyrazoles | PPIP5K2, PCK2, PFKFB4 | PKM 828/4885SMN1; SMN2 4803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.